OLMA
$3.91
Olema Pharmaceuticals
($.36)
(8.43%)
OLMA
Earnings Whisper ®
N/A
3rd Quarter September 2022
Consensus:  ($0.79)
Revenue:  N/A
Tuesday
Nov 8
4:35 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when OLMA reports earnings?
Beat
Meet
Miss

Where is OLMA's stock price going from here?
Up
Flat
Down
Stock chart of OLMA
Analysts
Summary of analysts' recommendations for OLMA
Score
Grade
Pivots
Resistance
$4.39
$4.28
$4.09

$3.98

Support
$3.79
$3.68
$3.49
Tweet
Growth
Description
Olema Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in discovery, development and commercialization of therapies for women's cancers. The company's product pipeline includes OP-1250, which is in clinical stage. Olema Pharmaceuticals Inc. is based in San Francisco, California.